F. Mühlbacher

A paired-kidney allocation study found superior survival with HLA-DR compatible kidney transplants in the Eurotransplant Senior Program.
202316 citationsauthor #45
Letter to the editor
20200 citationsauthor #2
Efficacy and safety of tacrolimus compared with ciclosporin‐A in renal transplantation: 7‐year observational results
201623 citationsauthor #14
Kidney Transplantation With Corticosteroids Alone After Haploidentical HSCT From The Same Donor
201614 citationsauthor #7
Tacrolimus, Mycophenolate Mofetil, and Low-Dose Steroids With or Without Interleukin-2 Receptor Antibody Induction Therapy: A Retrospective Cohort Analysis.
20153 citationsauthor #9
Assessing the TP53 marker type in patients treated with or without neoadjuvant chemotherapy for resectable colorectal liver metastases: a p53 Research Group study.
201524 citationsauthor #10
Chapter 18 – Transplantation for Metastases
20151 citationsauthor #1
Long‐term outcome of belatacept therapy in de novo kidney transplant recipients – a case‐match analysis
201516 citationsauthor #10
Belatacept treatment for two yr after liver transplantation is not associated with operational tolerance
201515 citationsauthor #6
Abdominal drainage after liver transplantation from deceased donors
20159 citationsauthor #6
Gender has no influence on VUR rates after renal transplantation
201414 citationsauthor #3
Ongoing Success
20140 citationsauthor #1
Pre-Implant Biopsy Predicts Outcome of Single-Kidney Transplantation Independent of Clinical Donor Variables
201436 citationsauthor #6
369. Assessing the predictive and prognostic value of the biomarker TP53 in patients with resectable colorectal liver metastases treated with and without neoadjuvant fluorouracil based chemotherapy: A p53 research group study
20141 citationsauthor #9
Peri-Transplant Immunoadsorption for Donor-Specific Antibody Positive Recipients of a Deceased Donor Kidney Allograft With or Without a Positive Current Cytotoxic Crossmatch.: Abstract# A157
20140 citationsauthor #5
The efficacy and safety of cyclosporine reduction in de novo renal allograft patients receiving sirolimus and corticosteroids: results from an open‐label comparative study
201413 citationsauthor #1
Ultra-high-risk pregnancies in women after renal transplantation.
201417 citationsauthor #5
Fasting and postprandial liver glycogen content in patients with type 1 diabetes mellitus after successful pancreas–kidney transplantation with systemic venous insulin delivery
201410 citationsauthor #10
after Successful Liver Transplantation Haemophilus parainfluenzae Liver Abscess
20130 citationsauthor #1
Solid phase detection of C4d‐fixing HLA antibodies to predict rejection in high immunological risk kidney transplant recipients
201340 citationsauthor #7
miRNA Profiling Discriminates Types of Rejection and Injury in Human Renal Allografts
201389 citationsauthor #6
Long‐Term Exposure to Belatacept in Recipients of Extended Criteria Donor Kidneys
201380 citationsauthor #9
The effect of steroid pretreatment of deceased organ donors on liver allograft function: A blinded randomized placebo-controlled trial
201229 citationsauthor #6
Dynamic changes in MELD score not only predict survival on the waiting list but also overall survival after liver transplantation
201239 citationsauthor #8
Early basal insulin therapy decreases new-onset diabetes after renal transplantation.
2012214 citationsauthor #11
The cutting (w)edge--comparative evaluation of renal baseline biopsies obtained by two different methods.
201219 citationsauthor #5
Simultaneous pancreas-kidney transplantation nine years after liver transplantation--a case report.
20122 citationsauthor #7
Liver transplantation: impaired biliary excretion of gadoxate is associated with an inferior 1-year retransplantation-free survival.
201211 citationsauthor #6
25 and going strong
20122 citationsauthor #1
Outcome of patients with Child-Pugh C liver cirrhosis and hepatocellular carcinoma after liver transplantation
20110 citationsauthor #8
Effect of intraportal infusion of tacrolimus on ischaemic reperfusion injury in orthotopic liver transplantation: a randomized controlled trial
201122 citationsauthor #6
Five-year safety and efficacy of belatacept in renal transplantation.
2010168 citationsauthor #10
Identification of Non-HLA antigens targeted by alloreactive antibodies in patients undergoing chronic hemodialysis.
201029 citationsauthor #12
Visible Progress
20101 citationsauthor #1
51st Annual Meeting of the Austrian Society of Surgery. Linz, June 2–4, 2010. Guest Editors: Ferdinand Mühlbacher, Gabriela A. Berlakovich, Rudolf Steininger
20100 citationsauthor #4
33rd Seminar of the Austrian Society for Surgical Research. Wagrain, November 19–21, 2009. Guest Editor: Th. Wekerle, Wien, Austria
20090 citationsauthor #12
Vienna experience of ABO-incompatible living-donor kidney transplantation
200921 citationsauthor #9
CO.13 Quinze annes dvolution des rsultats de la transplantation hpatique en Europe
20090 citationsauthor #13
Raising the benchmark
20090 citationsauthor #1
Effect of Hemodialysis Before Transplant Surgery on Renal Allograft Function—A Pair of Randomized Controlled Trials
200924 citationsauthor #7
23rd Meeting of the Austrian Society of Transplantation, Transfusion and Genetics. Seefeld, October 21–23, 2009. Guest Editor: Walter Mark, Innsbruck, Austria
20090 citationsauthor #7
Book Review
20080 citationsauthor #1
Next level
20080 citationsauthor #1
Efficacy and safety of tacrolimus compared with ciclosporin A in renal transplantation: three-year observational results.
200853 citationsauthor #16
ELPAT, the European platform on ethical, legal and psychosocial aspects of organ transplantation
20082 citationsauthor #2
TEN-YEAR FOLLOW-UP OF A MULTICENTRE KIDNEY TRANSPLANT STUDY DISCLOSE HIGHER GRAFT SURVIVAL AND BETTER RENAL FUNCTION IN TACROLIMUS THERAPY: 625
20080 citationsauthor #9
Ten-year follow-up of the first multicenter, randomized, kidney transplant study shows better graft function in tacrolimus-treated patients
20080 citationsauthor #8
NON-HEART BEATING DONATION IN EUROPE; AN OVERVIEW: 1804
20080 citationsauthor #3
Analysis of liver function in renal transplant recipients undergoing C2‐monitoring for cyclosporine
20082 citationsauthor #11
CD26/DPPIV ENZYMATIC INHIBITION IN A MURINE MODEL OF MIXED CHIMERISM.: 2230
20080 citationsauthor #8
Contents Vol. 74, 2006
20070 citationsauthor #7
MR‐guided percutaneous ethanol ablation of hepatocellular carcinomas before liver transplantation
20073 citationsauthor #6
Short‐term induction therapy with anti‐thymocyte globulin and delayed use of calcineurin inhibitors in orthotopic liver transplantation
200781 citationsauthor #7
Subject Index Vol. 74, 2006
20070 citationsauthor #7
Short‐term versus long‐term induction therapy with antithymocyte globulin in orthotopic liver transplantation
200725 citationsauthor #7
Prophylactic Bisphosphonate Treatment Prevents Bone Fractures After Liver Transplantation
200761 citationsauthor #13
Present status at the Vienna Transplantation Center after four thousand renal transplantations.
20070 citationsauthor #11
On course
20070 citationsauthor #1
Graft versus Host Disease after Orthotopic Liver Transplantation Documented by Analysis of Short Tandem Repeat Polymorphisms
200714 citationsauthor #8
Granulocyte-based immune response against decellularized or glutaraldehyde cross-linked vascular tissue.
200649 citationsauthor #5
Alemtuzumab (Campath-1H) induction therapy and dendritic cells: Impact on peripheral dendritic cell repertoire in renal allograft recipients.
200627 citationsauthor #6
12‐month follow‐up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus
2006102 citationsauthor #5
Full speed ahead
20060 citationsauthor #1
Long-term outcomes in liver transplant patients with hepatic C infection receiving tacrolimus or cyclosporine.
200630 citationsauthor #10
Liver transplantation for hepatic malignancies
20061 citationsauthor #3
Graft versus host reaction after orthotopic liver transplantation
20050 citationsauthor #8
Osteoclast-like giant cell tumor in mucinous cystadenocarcinoma of the pancreas: an immunohistochemical and molecular analysis.
200526 citationsauthor #7
16 – Liver Transplantation for Metastases of the Liver
20050 citationsauthor #1
Does Additional Doxorubicin Chemotherapy Improve Outcome in Patients with Hepatocellular Carcinoma Treated by Liver Transplantation?
200564 citationsauthor #8
Off to New Horizons
20051 citationsauthor #1
C2 versus C0 cyclosporine monitoring : The end for us
20052 citationsauthor #4
Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
2005135 citationsauthor #13
Transplant International adopts the policy of a uniform clinical trial registration
20050 citationsauthor #1
Anatomic basis of right renal vein extension for cadaveric kidney transplantation.
200484 citationsauthor #9
Histidine‐tryptophan‐ketoglutarate solution for organ preservation in human liver transplantation—a prospective multi‐centre observation study
200411 citationsauthor #9
Prevalence of anal HPV infection in solid-organ transplant patients prior to immunosuppression
200457 citationsauthor #5
Prevalence of anal HPV infection in solid‐organ transplant patients prior to immunosuppression
20047 citationsauthor #5
COMPARISON BETWEEN C0 AND C2 MONITORING IN DE NOVO RENAL TRANSPLANT RECIPIENTS
20040 citationsauthor #9
Comparison Between C0 And C2 Monitoring in De Novo Renal Transplant Recipients: Retrospective Analysis of a Single-Center Experience
200422 citationsauthor #8
Histidine–tryptophan–ketoglutarate solution for organ preservation in human liver transplantation—a prospective multi-centre observation study
200458 citationsauthor #9
Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor
200496 citationsauthor #2
Genome-wide gene-expression patterns of donor kidney biopsies distinguish primary allograft function
2004110 citationsauthor #5
Genetic Detection of Lymph Node Micrometastases: A Selection Criterion for Liver Transplantation in Patients with Liver Metastases after Colorectal Cancer
200443 citationsauthor #12
Acute colonic pseudo-obstruction (Ogilvie’s-syndrome) and Pneumatosis intestinalis in a kidney recipient patient
20034 citationsauthor #8
Changes, achievements, and improvements
20030 citationsauthor #1
Chemoembolization with cisplatin, lipiodol and Gelfoam and subsequent systemic chemotherapy with cisplatin and interferon in patients with hepatocellular carcinoma: a non-randomized prospective study.
20036 citationsauthor #6
Resection of Hilar Cholangiocarcinomas: Pivotal Prognostic Factors and Impact of Tumor Sclerosis
200321 citationsauthor #11
Which ABO‐matching rule should be the decisive factor in the choice between a highly urgent and an elective patient?
20027 citationsauthor #9
Targeting the ERK-1/2 signalling pathway results in alloantigen-specific anergy in human T cells.
20023 citationsauthor #4
Tolerance induction through mixed chimerism
20021 citationsauthor #7
Which ABO-matching rule should be the decisive factor in the choice between a highly urgent and an elective patient?
20026 citationsauthor #9
Fresh arterial homograft transplantation: a novel concept for critical limb ischaemia.
200228 citationsauthor #5
Current value of intraoperative sonography during surgery for hepatic neoplasms
2002151 citationsauthor #9
Substantial changes in Transplant International
20020 citationsauthor #1
Accuracy of Multiphasic Helical Computed Tomography and Intraoperative Sonography in Patients Undergoing Orthotopic Liver Transplantation for Hepatoma: What is the Truth?
200249 citationsauthor #9
Analysis of hepatic resection of metastasis originating from gastric adenocarcinoma
2002113 citationsauthor #6
European Surgery ACA Acta chirurgica Austriaca 2002
20021 citationsauthor #9
Multiorgan donation from a donor with unrecognized ornithine transcarbamylase deficiency
200121 citationsauthor #9
Tacrolimus versus cyclosporin microemulsion in liver transplantation: results of a 3-month study.
200124 citationsauthor #1
DOSE OPTIMIZATION OF MYCOPHENOLATE MOFETIL WHEN ADMINISTERED WITH A LOW DOSE OF TACROLIMUS IN CADAVERIC RENAL TRANSPLANT RECIPIENTS
2001135 citationsauthor #11

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT